Surmodics reported $31.15M in Cash and Equivalent for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Align Technology ALGN:US $ 1237.82M 151.46M
Anika Therapeutics ANIK:US $ 90.98M 6.2M
Arrowhead Research ARWR:US $ 184.43M 141.55M
Baxter International BAX:US $ 3258M 122M
Bioscrip BIOS:US $ 200.86M 43.33M
Cryolife CRY:US $ 64.59M 14.11M
Edap Tms EDAP:US $ 45.41M 0.45M
Edwards Lifesciences EW:US $ 1506.9M 194.1M
Genmark Diagnostics GNMK:US $ 40.57M 17.24M
Haemonetics HAE:US $ 192.42M 18.96M
Heron Therapeutics HRTX:US $ 159.57M 31.6M
Merit Medical Systems MMSI:US $ 68.9M 0.77M
Mesa Laboratories MLAB:US $ 278.29M 2.58M
Nektar Therapeutics NKTR:US $ 54.02M 98.33M
Oxford Immunotec Global OXFD:US $ 160.62M 4.87M
Providence Service PRSC:US $ 126.51M 164.4M
Stryker SYK:US $ 2563M 322M
Surmodics SRDX:US $ 31.15M 31.02M
Trinity Biotech TRIB:US $ 27.48M 1.14M